CLIATALK 2023: Mindray sponsors international exchange program

To promote cross-border communication and knowledge sharing among immunoassay and laboratory experts, Mindray proudly sponsored the CLIATALK 2023 international exchange program. Held from July 4 to July 9, the program centered around the theme of “Mindray Tumor Marker Total Solution and Laboratory Development”. The event offered a valuable platform for experts from across the globe to fully immerse themselves in China’s ever-evolving laboratory diagnostics field and gain diverse perspectives on immunoassay.

In Shenzhen: Strengthening Collaborations for Advancing Medical Diagnostics
On July 5, Mindray hosted a select group of distinguished guests from Russia, Mongolia, Uzbekistan, Iraq, Pakistan, Indonesia, and other countries, including Professor Khosrow Adeli, the president of IFCC, at the headquarters in Shenzhen, China.

During the visit to Mindray’s new exhibition hall and production facility in Shenzhen, the guests had the opportunity to explore how Mindray’s innovative technology brings real value to medical diagnostics. Mindray also organized an informative meeting where the customers got to exchange with the IVD team and learned about Mindray’s new parameters including the Immunoassay Total Solution alongside the value-added services that it provides.

This visit and exchange not only deepened the customers’ understanding of Mindray and its commitment to providing high-quality medical device solutions, but it also laid a solid foundation for future meaningful partnerships between healthcare organizations and Mindray to drive positive change in the industry.

In Hangzhou: Academic exchange on laboratory medicine development
Round table at Sir Run Run Shaw Hospital

Mindray tumor marker total solution academic seminar
Cancer is the leading cause of disease globally, with an astonishing yearly incidence of approximately 20 million new cases. To better meet the clinical needs for cancer management, raise public awareness about cancer prevention, and promote the Mindray Tumor Marker Total Solution, the “Mindray Tumor Marker Total Solution Academic Seminar” took place on July 8.

Throughout the academic conference sessions, the focal point of discussions revolved around the latest research advancements and practical applications of tumor biomarkers. The topics included current research trends and technological innovations, potential applications in real-world projects, as well as the sharing of clinical case studies.

Given the ever-increasing challenges in cancer diseases, early diagnosis and treatment, along with effective diagnostics and precise treatments, will be pivotal in cancer prevention and control. These efforts rely on robust support from advancements in laboratory technology. Mindray, being a leading IVD solutions provider in China, is actively driving technological innovation and expanding its global footprint. Besides offering IVD total solutions to global users, Mindray strives to foster open communication and exchange within the global medical community, promoting progress in various medical disciplines and specialized technologies. The goal is to drive change in the industry for enhanced medical efficiency and better patient outcomes.
MB Bureau